论文部分内容阅读
目的探讨参芪扶正注射液(丽珠医药)对提高老年恶性肿瘤患者化疗耐受性的应用效果。方法 68例老年恶性肿瘤患者分为研究组和对照组,各34例,研究组患者均给予化学药物+参芪扶正注射液(丽珠医药)联合治疗;对照组患者化疗治疗措施同研究组,不加用参芪扶正注射液。对比两组患者治疗后不良反应发生率,给予统计学分析并得出结论。结果研究组中断化疗0例、对照组7例(20.59%)中断化疗,研究组老年恶性肿瘤患者化疗过程中不良反应发生率显著低于对照组,对比结果差异具有统计学意义(P<0.05)。结论对老年恶性肿瘤患者进行化疗时加用参芪扶正注射液可显著提高其对化疗耐受性,利于患者顺利完成化疗,保障其疗效及预后。
Objective To investigate the effect of Shenqi Fuzheng Injection (Livzon) on improving chemotherapy tolerance in elderly patients with malignant tumor. Methods Sixty-eight elderly patients with malignant tumor were divided into study group and control group, with 34 cases in each group. All the patients in the study group were given the combination of chemical drugs and Shenqi Fuzheng Injection (Livzon). The control group patients with chemotherapy treatment were the same as the study group, Without adding Shenqi Fuzheng injection. The incidence of adverse reactions was compared between the two groups after treatment, statistical analysis was given and conclusions were drawn. Results In the study group, 0 patients discontinued the chemotherapy and 7 patients (20.59%) in the control group discontinued the chemotherapy. The incidence of adverse reactions in the study group was significantly lower than that in the control group (P <0.05) . Conclusion Chemotherapy combined with Shenqi Fuzheng injection in elderly patients with malignant tumor can significantly improve its tolerance to chemotherapy and facilitate the successful completion of chemotherapy to ensure its efficacy and prognosis.